Navigation Links
Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference

SAN FRANCISCO, March 19, 2007 /PRNewswire-FirstCall/ -- Medivation, Inc. today announced that six-month results from its randomized, double-blinded, placebo-controlled Phase 2 efficacy trial of Dimebon(TM) in patients with mild-to-moderate Alzheimer's disease demonstrated that patients treated with Dimebon were significantly improved compared to patients taking placebo on all five efficacy endpoints studied, which assessed cognitive function, memory, ability to perform tasks of daily living, global function and behavior.

Full top-line data from this trial were presented yesterday for the first time as an oral presentation (abstract #1662) at the 8th International Conference on Alzheimer's and Parkinson's Diseases: Progress and New Perspectives, in Salzburg, Austria, by the study's lead investigator, Rachelle S. Doody, M.D., Ph.D., the Effie Marie Cain Chair in Alzheimer's Disease Research at the Alzheimer's Disease and Memory Disorders Center, in Houston.

New data presented in Salzburg included the magnitude and levels of statistical significance by which the Dimebon-treated patients outperformed the placebo-treated patients on the Mini Mental State Exam (MMSE: p<0.0001), the Alzheimer's Disease Cooperative Study Group-Activities of Daily Living (ADCS-ADL: p=0.002), and the Neuropsychiatric Inventory (NPI: p=0.006). As previously reported, Dimebon-treated patients also demonstrated significant improvement versus placebo on both the primary and key secondary endpoints in this study -- the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog: p<0.0001) and the Clinician's Interview-Based Impression of Change with a caregiver interview (CIBIC-plus: p<0.0001). Dimebon was well tolerated in this study.

"In my experience, the results of this study are particularly striking for two primary reasons," said Dr. Doody. "First, Dimebon produced statistically significant improvement over pl
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
2. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
3. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Medivation Announces First U.S. Presentation of Data From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:12/22/2014)... Dec. 22, 2014 NxStage Medical, Inc. (NASDAQ: ... innovative dialysis products, announced today that the U.S. ... System One™ to perform hemodialysis overnight while the ... nocturnal hemodialysis. NxStage,s® System One is the first ... for this indication. Home nocturnal ...
(Date:12/22/2014)... a privately-held medical products and technologies company, today announced ... Officer of the company, effective December 22, 2014. ... Board of Directors of ConvaTec thanks Mr. Berger for ... years," said Magnus Lundberg , the Chairman of ... company is well positioned for the future."  The company ...
(Date:12/22/2014)... Calif. , Dec, 22, 2014  Eiger ... Phase 2a study of lonafarnib in patients with ... was conducted at the National Institutes of Health ... .  The double-blinded, randomized, placebo-controlled, dose ascending ... twice daily and 200 mg twice daily for ...
Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
(Date:12/22/2014)... recognition of Veteran’s Day, Discount Labels contributed a portion ... that provides services to veterans and their families, free ... hundred acres in the hills of Southern Indiana, the ... hiking, horseback riding, 4-wheeling, skeet shooting, and much more. ... U.S. Service men and women, police officers, fire fighters ...
(Date:12/22/2014)... Pasadena sleep apnea dentist, Dr. ... Drowsy drivers are 15 times more likely to cause ... some experts believe that sleep-deprived drivers may be just ... millions of Americans may be sleep-deprived without even knowing ... about 18 million Americans have sleep apnea, but as ...
(Date:12/22/2014)... 2014 7,178 small business owners and ... Friday shopping and opted instead to join Digital Marketer, ... for their 5th annual “Black Friday Boot Camp”. ... to attend the 5 hour online training event and ... to support two Central Texas based charities dedicated to ...
(Date:12/22/2014)... December 22, 2014 Luxury Linen purveyor ... Partners of Dallas to provide logistics and support for ... Peacock Alley has a long history of giving back to ... sponsors of this year's Toy Drive were Whataburger® and 99.5 ... back than the holidays. Providing gifts to children who would ...
(Date:12/22/2014)... Garden City, NY (PRWEB) December 22, 2014 ... as a 2014 Professional Woman of the Year. ... leadership in business. As the largest, most-recognized networking organization ... industry and profession, the National Association of Professional Women ... members and nearly 300 Local Chapters. , “As a ...
Breaking Medicine News(10 mins):Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2Health News:Pasadena Dentist, Dr. Marine Martirosyan, Now Offers Consultations for Sleep Apnea 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2Health News:National Association of Professional Women Announces Michelle M. Foley, Vice President of Operations of OTTR Chronic Care Solutions, a 2014 Professional Woman of the Year 2
... , ... Expand Products/Services Options , ... Philadelphia, PA (Vocus) October 6, 2009 -- GlobalSubmit Inc. ( www.globalsubmit.com ), a ... Technical Document (eCTD) global submissions, announces that it is extending its Signature Partners Program ...
... 6 Crunch announces the first annual Crunch-a-thon, a ... Augie,s Quest, in an effort to help find a ... to helping this organization continue its quest through the ... and group personal training sessions at every Crunch location ...
... It Began Oct. 9, 1877 , DENVER, Oct. 6 ... children were often toiling at hard labor in filthy sweatshops instead ... were forced into the bustling streets or garbage-strewn alleys instead of ... nearly starved or dehydrated - were forced to work 20-hour days. ...
... 6 While end-of-life care issues have come front ... physicians in the Pacific Northwest can now get more ... and hospice care. , The new Palliative Medicine Fellowship ... of Washington, is a cooperative effort between Providence Hospice ...
... Health Plan, Inc., announced today the debut of ... in California, Missouri, New Hampshire and Virginia, as ... Maine and Texas. Its sister organizations and corresponding ... York, Oklahoma, and North Carolina. Providing Medicare Advantage ...
... if headphones hang close to chest, study shows, , ... offers more evidence that portable headphones can create magnetic ... , Using the headphones over the ears doesn,t ... a shirt or jacket pocket near the chest or ...
Cached Medicine News:Health News:GlobalSubmit Extends Signature Partnership Program 2Health News:Crunch to Host Nationwide Fundraising Event to Support Augie's Quest 2Health News:132nd Anniversary Nears for American Humane Association 2Health News:132nd Anniversary Nears for American Humane Association 3Health News:132nd Anniversary Nears for American Humane Association 4Health News:132nd Anniversary Nears for American Humane Association 5Health News:New Palliative Medicine Fellowship Created to Train Pacific Northwest Doctors in End-of-Life Care 2Health News:New Palliative Medicine Fellowship Created to Train Pacific Northwest Doctors in End-of-Life Care 3Health News:Arcadian Health Plans Expand Their Medicare Health Plan Offerings and Enter Four New States 2Health News:Headphones May Threaten Heart-Device Performance 2
Latex agglutination slide test for the qualitative and quantitative detection of rubella virus antibody in serum....
Hemagglutination slide test for the qualitative and quantitative detection of Rheumatoid Factor in serum or synovial fluid....
A Color-Enhanced Slide Agglutination Test for the Rapid Qualitative and Semi-Quantitative Detection of Rheumatoid Factor in Serum....
Hemagglutination slide test for the qualitative and quantitative detection of infectious mononucleosis heterophile antibodies in serum or plasma....
Medicine Products: